170 related articles for article (PubMed ID: 16709820)
1. Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer.
Sfondrini L; Rossini A; Besusso D; Merlo A; Tagliabue E; Mènard S; Balsari A
J Immunol; 2006 Jun; 176(11):6624-30. PubMed ID: 16709820
[TBL] [Abstract][Full Text] [Related]
2. Flagellin is a Th1 polarizing factor for human CD4
Labastida-Conde RG; Ramírez-Pliego O; Peleteiro-Olmedo M; Lopez-Guerrero DV; Badillo-Godinez OD; Gutiérrez-Xicoténcatl ML; Rosas-Salgado G; González-Fernández Á; Esquivel-Guadarrama FR; Santana MA
Vaccine; 2018 Jul; 36(29):4188-4197. PubMed ID: 29891347
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.
Marshall NA; Galvin KC; Corcoran AM; Boon L; Higgs R; Mills KH
Cancer Res; 2012 Feb; 72(3):581-91. PubMed ID: 22158905
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Denatured Flagellin on Toll-Like Receptor-5 (TLR-5) in Mice.
Mcheik S; Al-Akl NS; Abdelnoor AM
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):412-416. PubMed ID: 29589550
[TBL] [Abstract][Full Text] [Related]
5. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
6. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
[TBL] [Abstract][Full Text] [Related]
7. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA
Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
[TBL] [Abstract][Full Text] [Related]
9. Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice.
Wagner S; Jasinska J; Breiteneder H; Kundi M; Pehamberger H; Scheiner O; Zielinski CC; Wiedermann U
Breast Cancer Res Treat; 2007 Nov; 106(1):29-38. PubMed ID: 17203384
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.
Shi X; Cao S; Mitsuhashi M; Xiang Z; Ma X
J Immunol; 2004 Apr; 172(7):4111-22. PubMed ID: 15034023
[TBL] [Abstract][Full Text] [Related]
11. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
[TBL] [Abstract][Full Text] [Related]
12. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
[TBL] [Abstract][Full Text] [Related]
13. F18
Won G; Lee JH
Comp Immunol Microbiol Infect Dis; 2018 Jun; 58():44-51. PubMed ID: 30245050
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
15. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
Schülke S; Burggraf M; Waibler Z; Wangorsch A; Wolfheimer S; Kalinke U; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2011 Dec; 128(6):1340-1348.e12. PubMed ID: 21872305
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
[TBL] [Abstract][Full Text] [Related]
18. Treatment with ligands for toll-like receptors 2 and 5 induces a mixed T-helper 1- and 2-like response in chicken splenocytes.
St Paul M; Paolucci S; Sharif S
J Interferon Cytokine Res; 2012 Dec; 32(12):592-8. PubMed ID: 23030671
[TBL] [Abstract][Full Text] [Related]
19. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo.
Allen SD; Garrett JT; Rawale SV; Jones AL; Phillips G; Forni G; Morris JC; Oshima RG; Kaumaya PT
J Immunol; 2007 Jul; 179(1):472-82. PubMed ID: 17579068
[TBL] [Abstract][Full Text] [Related]
20. Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity.
Dredge K; Marriott JB; Todryk SM; Muller GW; Chen R; Stirling DI; Dalgleish AG
J Immunol; 2002 May; 168(10):4914-9. PubMed ID: 11994441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
